MMedication Read More Nearly 90,000 bottles of children’s liquid pain medication recalledMarch 22, 2026 WASHINGTON (AP) — Nearly 90,000 bottles of a children’s pain reliever have been recalled due to reports of…
MMedication Read More Nearly 90,000 bottles of children’s liquid pain medication recalledMarch 22, 2026 WASHINGTON (AP) — Nearly 90,000 bottles of a children’s pain reliever have been recalled due to reports of…
MMedication Read More Coming Soon: ‘Wegovy HD’March 21, 2026 Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may…
NNutrition Read More Defining ‘ultraprocessed’ could spur research, school lunch rules – Roll CallMarch 20, 2026 The Trump administration is nearing a key milestone in its “Make America Healthy Again” agenda: proposing a definition of…
MMedication Read More FDA issues CRL to Aldeyra’s reproxalap drug applicationMarch 19, 2026 The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) to Aldeyra Therapeutics for…
MMedication Read More Mothers ‘Terrified’ as Children Could Lose Treatments After FDA DenialsMarch 17, 2026 Mothers from across the country have spoken to Newsweek about their concern for their children after the Food…
NNutrition Read More Multivitamin Recall Update for 25 States As FDA Sets Risk LevelMarch 14, 2026 A chewable multivitamin distributed across 25 states has been recalled after federal inspectors found the product contained lower‑than‑intended…
MMedication Read More FDA warns Novo Nordisk over unreported potential Ozempic side effectsMarch 10, 2026 Novo Nordisk, the pharmaceutical company behind Ozempic, has received a warning letter from the U.S. Food and Drug…
MMedication Read More Top FDA drug official is trying to hire a friend who’s seeking a bold new warning on antidepressantsMarch 8, 2026 WASHINGTON (AP) — The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to…
MMedication Read More FDA sends warning to 30 telehealth companies selling ‘illegal’ GLP-1sMarch 6, 2026 The Food and Drug Administration (FDA) on Tuesday sent 30 telehealth companies warning letters about their “illegal” sales…
HHealthcare Read More Eli Lilly on track to launch oral obesity drug in second quarter, pending US approvalMarch 5, 2026 March 2 (Reuters) – Eli Lilly CFO Lucas Montarce said on Monday it is preparing to launch its…
MMedication Read More FDA to offer bonus payments to staffers who complete speedy drug reviewsMarch 1, 2026 WASHINGTON (AP) — The head of the Food and Drug Administration plans to start offering bonus payments to…